HPV, HPV Vaccine
Conditions
Brief summary
The purpose of the study is to assess Human Papillomavirus (HPV) and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences for learning more about HPV and HPV vaccination and to receive feedback on and adapt HPV educational materials for Young Latino Men who have Sex with Men (YLMSM).
Detailed description
To assess HPV and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences among 260 Spanish-speaking YLMSM ages 18-26 in Florida and Puerto Rico. To conduct 20 in-depth interviews with key stakeholders (10 in PR and 10 in FL) eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation. To culturally adapt an existing Cancer 101 educational resource in English and Spanish for YLMSM ages 18-26 and to conduct focus groups or individual interviews with 24 YLMSM in PR (n=12) and FL (n=12) to gain feedback on the acceptability, accessibility, content, delivery preferences, and aesthetics of the theoretically informed, HPV educational intervention targeted for English and/or Spanish-speaking YLMSM.
Interventions
Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.
In-depth interviews (n=20) will be conducted with key stakeholders (10 in PR and 10 in FL) eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.
Sponsors
Study design
Eligibility
Inclusion criteria
for Aim 1 & 3: * Men who have had sex with a man and/or are attracted to men * Hispanic/Latino ethnicity * Able to read, write and understand Spanish (for Aim 1) and Spanish or English (for Aim 3) * Aged 18-26 years * Primary residence in either Puerto Rico or Florida * Has access to the internet (Aim 1 only) Additional criteria for Aim 3: * Has regular access to a working telephone or be able to attend an in-person focus group (modifications related to COVID-19 situation will allow virtual modality to complete the focus groups or individual interviews). * Able to read, write and understand Spanish or English Inclusion Criteria for Aim 2: * Individuals with a current or prior role (within last twelve months) in a community-based organization, private or public healthcare clinic, health department, college/university organization, or interest group that provides services to sexual minorities in FL or PR as a healthcare provider, staff member, group member, or in a leadership role * Age 21 or older * Able to understand, read and speak either Spanish or English * Access to a working telephone or computer
Exclusion criteria
for Aim 1 & 3: * Self identifies as either transman or transwoman * aged \<18 years or \>27 years * Individuals who contact the research team about interest in participating on Aims 1 or 3 (when recruitment cap has been completed for that aim) can be directed to Aims 1 or 3 for possible recruitment. Individuals can participate in more than 1 aim, but not more than one time in a single aim.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Part 1: HPV Vaccine Knowledge (Aim 1) | Day 1 | A scale consisting of 19 items (Score range 0-18) assessing general HPV knowledge and 9 items (Score range 0-9) assessing HPV vaccination-specific knowledge (modified from scales by Perez et al 2016 and Waller et al 2013, respectively), using a response scale consisting of True, False, and I don't know; higher scores mean higher knowledge. |
| Part 1: HPV Vaccine Awareness (Aim 1) | Day 1 | A scale consisting of 2 items from the Health Information National Trends Survey (HINTS) 2018, with response options Yes or No; Positive responses mean higher awareness |
| Part 1: HPV Vaccine Attitude (Aim 1) | Day 1 | A scale consisting of 8 items modified from the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS); with a 5-point response scale ranging from strongly disagree to strongly agree; higher scores mean stronger attitudes. The possible scale score range = 8-40. |
| Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | Day 1 | Participants will complete scales; a. Perceived Risk 5 point scale from no chance to Certain I will get; higher scores mean higher perceived risk; b. Descriptive norms scale from 0% to 100%, higher score mean greater descriptive norms; c. Perceived norms 8 point scale ranging from strongly disagree to strongly agree, not applicable, higher scores mean stronger perceived norms; d. Perceived Barriers 3-point scale ranging from Not concerned at all to Very concerned, higher scores mean higher perceived barriers; e. Self-efficacy scale ranging from Strongly agree to Strongly Disagree; lower scores mean higher self-efficacy. |
| Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) | Day 1 | Count of participants who responded what they thought their perceived risk is contracting HPV. Questions range from Much below average, below average, average risk, above average risk, much above average risk, and I don't know. |
| Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Day 1 | Count of participants who responded within each category asking intention to get HPV vaccine among those unvaccinated, using a 7-point scale ranging from Very unlikely to Very likely, higher scores mean stronger intentions. |
| Part 1: HPV Vaccine Behaviors 1 (Aim 1) | Day 1 | Count of participants who responded within each category that assesses past receipt of the HPV vaccine (modified from Brewer et al., 2009 and Brewer et al., 2017). Responses were: Yes, No, I don't know. |
| Part 1: HPV Vaccine Behaviors 2 (Aim 1) | Day 1 | Count of participants that self reported number of shots received among vaccinated individuals. Items range from 1 shot to I don't know. |
| Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Day 1 | A scale developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Who would you like to receive information from?. Options were Physician, Other healthcare provider (Nurse, Medical Assistant), Female peer, Male peer, Parent of teen, Parent of young adult, Someone who has survived an HPV-related Cancer Other. Participants marked all that applied. |
| Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Day 1 | Items developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Best method for delivering education?. 1 being the best method and 8 being the worst method. |
| Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Day 1 | An item developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, What age would it be most helpful to for a person to receive educational information? |
| Part 2: Facilitators and Barriers to Intervention Implementation (Aim 2) | Day 1 | Number of participants who consented and participated in individual interviews. |
| Part 3: Feedback From Focus Groups or Individual Interviews (Aim 3) | Day 1 | Number of Participants who completed either an individual interview or participated in a focus group. |
Countries
Puerto Rico, United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Aim 1 Only: Online Survey Group Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey.
Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences. | 117 |
| Aim 2 Only: Interview Group Individual interviews will be conducted with key healthcare stakeholders (i.e.,healthcare clinical leadership, providers and staff, community-based organization staff)
Interviews: In-depth interviews will be conducted with key stakeholders eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation. | 21 |
| Aim 3 Only: Focus Groups or Interview Group Each site will conduct focus groups or individual interviews with English or Spanish speaking young Latino men who have sex with men (YLMSM).
Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM. | 17 |
| Total | 155 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Lost to Follow-up | 0 | 0 | 1 |
| Overall Study | Protocol Violation | 0 | 1 | 0 |
| Overall Study | Withdrawal by Subject | 0 | 0 | 1 |
Baseline characteristics
| Characteristic | Aim 1 Only: Online Survey Group | Aim 2 Only: Interview Group | Aim 3 Only: Focus Groups or Interview Group | Total |
|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 117 Participants | 21 Participants | 17 Participants | 155 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 117 Participants | 11 Participants | 17 Participants | 145 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 0 Participants | 6 Participants | 0 Participants | 6 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 4 Participants | 0 Participants | 4 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 1 Participants | 0 Participants | 0 Participants | 1 Participants |
| Race (NIH/OMB) Asian | 1 Participants | 2 Participants | 0 Participants | 3 Participants |
| Race (NIH/OMB) Black or African American | 26 Participants | 2 Participants | 0 Participants | 28 Participants |
| Race (NIH/OMB) More than one race | 10 Participants | 0 Participants | 0 Participants | 10 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 2 Participants | 0 Participants | 0 Participants | 2 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 25 Participants | 10 Participants | 15 Participants | 50 Participants |
| Race (NIH/OMB) White | 52 Participants | 7 Participants | 2 Participants | 61 Participants |
| Region of Enrollment Puerto Rico | 96 participants | 11 participants | 13 participants | 120 participants |
| Region of Enrollment United States | 21 participants | 10 participants | 4 participants | 35 participants |
| Sex/Gender, Customized Female | 0 Participants | 6 Participants | 0 Participants | 6 Participants |
| Sex/Gender, Customized Male | 117 Participants | 12 Participants | 17 Participants | 146 Participants |
| Sex/Gender, Customized Unknown | 0 Participants | 3 Participants | 0 Participants | 3 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 | 0 / 0 |
Outcome results
Part 1: HPV Vaccine Attitude (Aim 1)
A scale consisting of 8 items modified from the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS); with a 5-point response scale ranging from strongly disagree to strongly agree; higher scores mean stronger attitudes. The possible scale score range = 8-40.
Time frame: Day 1
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Attitude (Aim 1) | 27.38 score on a scale | Standard Deviation 4.36 |
Part 1: HPV Vaccine Awareness (Aim 1)
A scale consisting of 2 items from the Health Information National Trends Survey (HINTS) 2018, with response options Yes or No; Positive responses mean higher awareness
Time frame: Day 1
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Awareness (Aim 1) | Ever Heard of HPV? | No | 21 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Awareness (Aim 1) | Ever Heard of HPV? | Yes | 81 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Awareness (Aim 1) | Ever Heard of HPV Vaccine? | No | 45 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Awareness (Aim 1) | Ever Heard of HPV Vaccine? | Yes | 57 Participants |
Part 1: HPV Vaccine Behaviors 1 (Aim 1)
Count of participants who responded within each category that assesses past receipt of the HPV vaccine (modified from Brewer et al., 2009 and Brewer et al., 2017). Responses were: Yes, No, I don't know.
Time frame: Day 1
Population: Missing data from 79 participants because orginal survey did not include this item, due to eligibility criteria at the time.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 1 (Aim 1) | Yes | 0 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 1 (Aim 1) | No | 17 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 1 (Aim 1) | I Don't Know | 6 Participants |
Part 1: HPV Vaccine Behaviors 2 (Aim 1)
Count of participants that self reported number of shots received among vaccinated individuals. Items range from 1 shot to I don't know.
Time frame: Day 1
Population: Analysis is of vaccinated participants
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 2 (Aim 1) | 1 Shot | 2 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 2 (Aim 1) | 2 Shots | 1 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 2 (Aim 1) | 3 Shots | 1 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 2 (Aim 1) | At Least 1 Shot, But I Don't Know How Many | 1 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 2 (Aim 1) | At Least 2 Shots, But I Don't Know How Many | 1 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Behaviors 2 (Aim 1) | I Don't Know | 2 Participants |
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
A scale developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Who would you like to receive information from?. Options were Physician, Other healthcare provider (Nurse, Medical Assistant), Female peer, Male peer, Parent of teen, Parent of young adult, Someone who has survived an HPV-related Cancer Other. Participants marked all that applied.
Time frame: Day 1
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Physicians | 96 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Other Healthcare Providers | 59 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Female Peer | 8 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Male Peer | 19 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Parent of Teen | 3 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Parent of Young Adult | 4 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | HPV Cancer Survivor | 40 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) | Other | 2 Participants |
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Items developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Best method for delivering education?. 1 being the best method and 8 being the worst method.
Time frame: Day 1
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 6 | 7 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 6 | 1 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 7 | 10 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 2 | 10 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 1 | 55 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 2 | 6 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 3 | 3 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 4 | 7 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 5 | 8 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | In Person | 8 | 12 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 1 | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 2 | 26 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 3 | 18 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 4 | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 5 | 9 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 7 | 8 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Website | 8 | 7 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 1 | 1 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 2 | 11 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 3 | 17 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 4 | 8 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 5 | 15 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 6 | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 7 | 18 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Smart Phone App | 8 | 19 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 1 | 2 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 2 | 15 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 3 | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 4 | 25 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 5 | 15 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 6 | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 7 | 9 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Online Webinar | 8 | 9 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 1 | 6 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 2 | 10 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 3 | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 4 | 12 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 5 | 11 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 6 | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 7 | 19 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Text Message | 8 | 17 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 1 | 2 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 2 | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 3 | 7 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 4 | 9 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 5 | 23 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 6 | 19 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 7 | 15 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Printed Booklet | 8 | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 1 | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 3 | 16 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 4 | 16 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 5 | 7 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 6 | 16 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 7 | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Social Media Platform | 8 | 11 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 1 | 10 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 2 | 11 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 3 | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 4 | 11 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 5 | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 6 | 19 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 7 | 10 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) | Healthcare System Portal | 8 | 13 Participants |
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
An item developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, What age would it be most helpful to for a person to receive educational information?
Time frame: Day 1
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 30-45 | Check | 18 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 9-10 | Missing | 89 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 9-10 | Check | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 11-14 | Missing | 74 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 11-14 | Check | 28 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 15-17 | Missing | 49 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 15-17 | Check | 53 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 18-22 | Missing | 50 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 18-22 | Check | 52 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 23-30 | Missing | 70 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 23-30 | Check | 32 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | Ages 30-45 | Missing | 84 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | I Do Not Think So | Missing | 102 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) | I Do Not Think So | Check | 0 Participants |
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
Participants will complete scales; a. Perceived Risk 5 point scale from no chance to Certain I will get; higher scores mean higher perceived risk; b. Descriptive norms scale from 0% to 100%, higher score mean greater descriptive norms; c. Perceived norms 8 point scale ranging from strongly disagree to strongly agree, not applicable, higher scores mean stronger perceived norms; d. Perceived Barriers 3-point scale ranging from Not concerned at all to Very concerned, higher scores mean higher perceived barriers; e. Self-efficacy scale ranging from Strongly agree to Strongly Disagree; lower scores mean higher self-efficacy.
Time frame: Day 1
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | Perceived Risk. 5 point scale with of Possible scale range 5-40 | 22.81 score on a scale | Standard Deviation 10.93 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | What percentage of peers do you think have received the HPV vaccine? Possible scale Range 0-100 | 20.01 score on a scale | Standard Deviation 22.78 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | What percentage of male peers do you think have received HPV vaccine? Possible scale Range 0-100 | 16.26 score on a scale | Standard Deviation 20.03 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | What percentage of gay/bisexual males do you think have received HPV vaccine? Possible Range 1-100 | 16.67 score on a scale | Standard Deviation 19.95 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | What percentage of female peers have received the HPV vaccine? Possible Scale Range 0-100 | 24.71 score on a scale | Standard Deviation 26.62 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | What percentage of gay/bisexual females received the HPV vaccine? Possible Scale Range 0-100 | 20.25 score on a scale | Standard Deviation 23.02 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | Perceived Norms. 8 items. Possible Score range 8-40 | 26.55 score on a scale | Standard Deviation 8.65 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | Perceived Barriers. 3 items. Possible score range 3-15. | 7.19 score on a scale | Standard Deviation 3.01 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) | SELFEFF1 - SELFEFF9. 9 items. Possible Score range 9-45. | 17.75 score on a scale | Standard Deviation 7.05 |
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)
Count of participants who responded what they thought their perceived risk is contracting HPV. Questions range from Much below average, below average, average risk, above average risk, much above average risk, and I don't know.
Time frame: Day 1
Population: Participants in analysis are unvaccinated.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) | Much below average | 27 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) | Below average | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) | Average risk (Same risk as others your age) | 29 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) | Above average | 6 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) | Much above average | 5 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) | I don't know | 21 Participants |
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Count of participants who responded within each category asking intention to get HPV vaccine among those unvaccinated, using a 7-point scale ranging from Very unlikely to Very likely, higher scores mean stronger intentions.
Time frame: Day 1
Population: Participants in analysis are unvaccinated.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get information about the HPV vaccine | Very Unlikey | 15 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get information about the HPV vaccine | Somewhat Unlikely | 2 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get information about the HPV vaccine | A Little Unlikely | 5 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get information about the HPV vaccine | Neither Unikely nor Likely | 13 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get information about the HPV vaccine | A Little Likely | 5 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get information about the HPV vaccine | Somewhat Likely | 26 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get information about the HPV vaccine | Very Likely | 36 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to obtain more than 1 shot in the next 12 months, | Very Unlikey | 14 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to obtain more than 1 shot in the next 12 months, | Somewhat Unlikely | 5 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to obtain more than 1 shot in the next 12 months, | A Little Unlikely | 5 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to obtain more than 1 shot in the next 12 months, | Neither Unikely nor Likely | 27 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to obtain more than 1 shot in the next 12 months, | A Little Likely | 8 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to obtain more than 1 shot in the next 12 months, | Somewhat Likely | 31 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to obtain more than 1 shot in the next 12 months, | Very Likely | 12 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get more than one dose in the future | Very Unlikey | 12 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get more than one dose in the future | Somewhat Unlikely | 9 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get more than one dose in the future | A Little Unlikely | 4 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get more than one dose in the future | Neither Unikely nor Likely | 20 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get more than one dose in the future | A Little Likely | 2 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get more than one dose in the future | Somewhat Likely | 24 Participants |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) | Intention to get more than one dose in the future | Very Likely | 31 Participants |
Part 1: HPV Vaccine Knowledge (Aim 1)
A scale consisting of 19 items (Score range 0-18) assessing general HPV knowledge and 9 items (Score range 0-9) assessing HPV vaccination-specific knowledge (modified from scales by Perez et al 2016 and Waller et al 2013, respectively), using a response scale consisting of True, False, and I don't know; higher scores mean higher knowledge.
Time frame: Day 1
Population: Unvaccinated participants only
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Knowledge (Aim 1) | HPV Knowledge (Scale Score range 0-18) | 10.10 score on a scale | Standard Deviation 4.87 |
| Aim 1 Only: Online Survey Group | Part 1: HPV Vaccine Knowledge (Aim 1) | HPV Vaccination Knowledge Scale (Score range 0-9) | 3.19 score on a scale | Standard Deviation 2.56 |
Part 2: Facilitators and Barriers to Intervention Implementation (Aim 2)
Number of participants who consented and participated in individual interviews.
Time frame: Day 1
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Aim 1 Only: Online Survey Group | Part 2: Facilitators and Barriers to Intervention Implementation (Aim 2) | 20 Participants |
Part 3: Feedback From Focus Groups or Individual Interviews (Aim 3)
Number of Participants who completed either an individual interview or participated in a focus group.
Time frame: Day 1
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Aim 1 Only: Online Survey Group | Part 3: Feedback From Focus Groups or Individual Interviews (Aim 3) | 13 Participants |